Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/04/2023 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 195k | $85.82 | $16.7M | | 08/04/2023 |
05/24/2023 | Karyopharm Therapeutics Inc. | KPTI | Grant | Nonstatutory Stock Option (right to buy) | 34k | $2.50 | $85k | | 05/24/2023 |
11/10/2022 | Sage Therapeutics, Inc. | SAGE | Purchase | Common Stock | 14.5k | $34.48 | $500k | | 11/10/2022 |
08/11/2022 | Karyopharm Therapeutics Inc. | KPTI | Exercise | Stock Option (right to buy) | 7.6k | $1.49 | $11.3k | | 08/11/2022 |
05/19/2022 | Karyopharm Therapeutics Inc. | KPTI | Grant | Nonstatutory Stock Option (right to buy) | 23.9k | $5.65 | $135k | | 05/19/2022 |
02/11/2022 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 69.9k | $43.04 | $3M | | 02/11/2022 |
08/05/2021 | Sage Therapeutics, Inc. | SAGE | Purchase | Common Stock | 23.6k | $43.15 | $1M | | 08/05/2021 |
06/16/2021 | Sage Therapeutics, Inc. | SAGE | Purchase | Common Stock | 8.8k | $56.32 | $495.6k | | 06/16/2021 |
06/02/2021 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 10k | $3.75 | $37.5k | | 06/02/2021 |
05/21/2021 | Karyopharm Therapeutics Inc. | KPTI | Grant | Nonstatutory Stock Option (right to buy) | 23.9k | $9.42 | $225.1k | | 05/21/2021 |
01/04/2021 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Options (Right to buy) | 390k | $85.82 | $33.5M | | 01/04/2021 |
10/01/2020 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Options (Right to buy) | 20k | $59.53 | $1.2M | | 10/01/2020 |
09/09/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 14.1k | $122.66 | $1.7M | | 09/09/2020 |
09/09/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 27.1k | $123.39 | $3.3M | | 09/09/2020 |
09/09/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 3.3k | $124.38 | $416.2k | | 09/09/2020 |
09/09/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 44.5k | $9.14 | $407k | | 09/09/2020 |
08/10/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 1.2k | $42.22 | $50k | | 08/10/2020 |
08/10/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 1.6k | $63.00 | $100k | | 08/10/2020 |
08/10/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 1.1k | $88.95 | $100k | | 08/10/2020 |
08/10/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 1k | $96.45 | $99.9k | | 08/10/2020 |
07/16/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Gift | Common Stock | 155 | $0.00 | $0 | by Dependent | 09/09/2020 |
07/16/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Gift | Common Stock | 3.2k | $0.00 | $0 | by Trust | 09/09/2020 |
07/16/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Gift | Common Stock | 3.2k | $0.00 | $0 | | 09/09/2020 |
06/15/2020 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 15k | $0.85 | $12.8k | | 06/15/2020 |
05/21/2020 | Karyopharm Therapeutics Inc. | KPTI | Grant | Nonstatutory Stock Option (right to buy) | 16.4k | $19.11 | $313.4k | | 05/21/2020 |
05/06/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 22.3k | $9.14 | $203.5k | | 05/06/2020 |
05/06/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 22.3k | $149.99 | $3.3M | | 05/06/2020 |
04/07/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Common Stock | 5.4k | $0.00 | $0 | | 04/07/2020 |
04/07/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Payment of Exercise | Common Stock | 1.6k | $104.75 | $167.5k | | 04/07/2020 |
04/07/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Payment of Exercise | Common Stock | 64 | $106.65 | $6.8k | | 04/07/2020 |
03/13/2020 | Karyopharm Therapeutics Inc. | KPTI | Exercise | Stock Option (right to buy) | 3k | $0.03 | $100 | | 03/13/2020 |
02/26/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 29.9k | $118.05 | $3.5M | | 02/26/2020 |
12/23/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Performance Stock Option 2017 (right to buy) | 10k | $119.13 | $1.2M | | 12/23/2019 |
11/22/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Performance Stock Option 2017 (right to buy) | 10k | $119.13 | $1.2M | | 11/22/2019 |
10/23/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Other (acquisition) | Common Stock | 5.5k | $0.00 | $0 | | 10/22/2019 |
|